A quotation for “Unicristin 1 mg” does not tell you whether the vial contains 1 mg in total, delivers 1 mg/mL, or comes in a different fill volume. By the end, you will be able to compare presentations, calculate usable supply, reject unsafe substitutions, and request the documents needed before releasing a vincristine shipment in Peru.
Key takeaways
- Confirm total milligrams and millilitres on every Unicristin vial.
- Match vincristine strength to the approved oncology protocol and route.
- Calculate doses, vial wastage, and reserve stock before ordering.
- Request cold-chain records, DIGEMID authorization, and batch documentation.
Read the vial label before comparing Unicristin strengths
A vial marked “Unicristin 1 mg” does not by itself tell you whether it contains 1 mg in total or has a concentration of 1 mg/mL.
Read the label and quotation together: confirm the active ingredient is vincristine sulfate, then check the concentration, fill volume, total vial content, dosage form, route, and number of vials in the pack.
- Find the strength statement, such as “1 mg/1 mL,” “1 mg/mL,” or “5 mg/5 mL.” “1 mg/mL” describes concentration; multiplied by the fill volume, it gives the total amount in the vial.
- Check whether the stated amount refers to vincristine sulfate or the convention used on the approved label. Do not compare a salt quantity with a different label basis as though they were identical.
- Confirm the container and presentation: single-dose vial, liquid injection, fill volume, and multi-vial pack. A box of ten 1 mg vials is not the same offer as one 10 mg vial.
- Ask the unicristin 1 mg supplier to state the manufacturer, exact presentation, local sanitary-registration number, and whether “1 mg” means total vial content.
- Compare the approved package insert before using dilution, infusion, excipient, storage, or in-use instructions from another product. Identical-looking strengths can carry different handling directions.
If the label omits concentration, volume, active ingredient, or route, pause the comparison and request a clear photograph of the vial, carton, and insert. A catalogue listing alone does not establish the product’s authorization in Peru.
Match vincristine to the protocol—and prevent a fatal route error
Choose vincristine only after the prescriber’s protocol identifies vincristine sulfate, not merely a cancer diagnosis or a “vinca” medicine. Vincristine, vinblastine and vinorelbine have different dosing schedules, toxicity profiles and protocol roles; liposomal vincristine is a separate formulation. Substituting one for another can deliver the wrong treatment.
| Drug | Protocol distinction | Procurement decision |
|---|---|---|
| Vincristine sulfate | Used as a component of specific combination regimens; dose and schedule depend on the protocol | Match the prescribed regimen, dose calculation and administration date |
| Vinblastine or vinorelbine | Different vinca alkaloids with different protocol uses and dosing | Do not substitute for vincristine sulfate |
| Liposomal vincristine | A distinct formulation, not an ordinary vincristine sulfate vial | Require explicit prescriber and protocol confirmation |
Before accepting an offer from a vincristine injection supplier in Lima, compare the prescribed product with the vial’s active ingredient, concentration, total content, dosage form and route. “1 mg” can mean 1 mg in the vial; “1 mg/mL” describes concentration.
A 1 mg/1 mL vial and a 5 mg/5 mL vial share concentration but not total content.
Vincristine is for intravenous administration only. Intrathecal administration is a recognized fatal medication error, so specify “for intravenous use only” on the purchase order, receiving record, storage bin and preparation procedure. Quarantine any presentation whose label, carton or protocol match leaves the route unclear.
Calculate usable vials, wastage and reserve stock
A 1 mg vial is not automatically a better fit than a 5 mg vial. Calculate from the prescribed dose in milligrams, the number of patients treated on each preparation day, the product’s total content per vial, and its single-dose handling limit.
A quotation from a “unicristin 1 mg supplier” must state whether 1 mg means total vial content or 1 mg/mL concentration, plus fill volume and pack size.
| Option | Usable-vial calculation | Waste and scheduling effect | Best fit |
|---|---|---|---|
| 1 mg total | Round each prescribed dose up to whole vials | Lowest remainder per opened vial; more units to receive and handle | Doses near 1 mg or irregular patient volume |
| 2 mg total | Divide the dose by 2 mg and round up | Moderate waste when doses fall below 2 mg | Repeated doses close to 2 mg |
| 5 mg total | Divide the dose by 5 mg and round up | Highest remainder risk for 1–2 mg doses; check single-dose discard rules | Several compatible doses prepared on one approved session |
For each treatment day, record prescribed milligrams, vials opened, milligrams administered, and milligrams discarded. Compare total cost per administered milligram, not only cost per vial; a cheaper 5 mg vial can cost more after unused product is discarded. Never pool leftovers unless the approved insert and validated hazardous-drug procedure explicitly permit it.
Set reserve stock against the next scheduled cycles, delivery lead time, quarantine time, and expected wastage. Keep enough sealed vials to cover confirmed doses plus documented loss, but do not build excess inventory that can expire or occupy hazardous-drug storage unnecessarily.
Verify the product, cold chain and Peruvian authorization
An offer described as unicristin injection wholesale peru is not ready for clinical use until the exact product matches Peru’s authorization record. Check vincristine sulfate injection, concentration in mg/mL, total vial content, fill volume, dosage form, intravenous-only route, manufacturer, manufacturing site, importer or registration holder, and DIGEMID sanitary-registration number.
| Product detail | Verify against | Reject or quarantine if |
|---|---|---|
| Brand and active ingredient | Unicristin; vincristine sulfate | It says vinblastine, vinorelbine, liposomal vincristine, or another ingredient |
| Strength and presentation | 1 mg/1 mL, 2 mg/2 mL, or 5 mg/5 mL only when approved for that product | “1 mg” cannot be matched to total content and concentration |
| Peruvian status | DIGEMID product information and approved labeling | The catalogue lists the product but no matching authorization |
| Batch identity | Lot number, expiry date, certificate of analysis, and release documents | The vial, carton, and documents show different details |
| Storage | Approved statement, usually 2–8 °C and protected from light | The supplier gives only “temperature controlled” |
Request the invoice, packing list, certificate of analysis, batch release certificate, GMP evidence for the named manufacturing site, and import or distribution documents identifying the Peruvian holder. Require temperature logger data for the entire shipment, the transport range, excursion procedure, and remaining shelf life.
Inspect for freezing, leakage, cracked vials, particles, discoloration, damaged seals, or missing labels; quarantine any discrepancy before release.
Compare a Lima supplier’s quotation on more than price per vial
A quotation is incomplete if it gives only “Unicristin 1 mg” and a price. For a unicristin injection for pharmaceutical supplier in Lima, require the active ingredient, concentration in mg/mL, total vial content, fill volume, dosage form, route, manufacturer, and Peruvian sanitary-registration number.
Ask the supplier to state:
- Whether the vial contains 1 mg total in 1 mL, or 1 mg/mL in another volume
- Whether the strength refers to vincristine sulfate and matches the approved label convention
- The price per vial, price per milligram, minimum order, expiry dates, and delivered cost
- Single-dose handling, expected opened-vial waste, replacement terms for breakage, and hazardous-drug transport packaging
- DIGEMID authorization for the exact manufacturer, importer or holder, strength, and presentation
Compare the offer on the same basis:
| Presentation | Price comparison | Main purchasing risk |
|---|---|---|
| 1 mg/1 mL | Highest flexibility for doses near 1 mg; calculate price per mg | More vials and handling for larger doses |
| 2 mg/2 mL | Compare price per mg and doses used per vial | Waste if prescriptions cluster below 2 mg |
| 5 mg/5 mL | Often lower nominal price per mg | Greater single-dose wastage for 1–2 mg doses |
Do not infer that a catalogue presentation is marketable in Lima. A vincristine injection supplier in Lima must support the exact product in DIGEMID’s pharmaceutical-product information systems. NIBA HEALTHCARE should provide the same evidence if its quotation is evaluated. Treat “unicristin injection wholesale peru” as a purchasing claim to verify, not proof of authorization.
Related product
![]() | VINCRISTINE SULFATE INJECTION USP Unicristin 1mg Injection is an anti-cancer medication used in the treatment of breast cancer, non-small cell lung cancer, pancreatic cancer, kidney... View product → |
Frequently asked questions
How do you compare Unicristin injection strengths?
Read the vial for both total content in milligrams and concentration in milligrams per millilitre; do not compare a label reading “1 mg” without confirming which figure it represents.
How do you prevent a fatal vincristine route error?
Match the product to the oncology protocol and verify the administration route before dispensing. Vincristine is for intravenous use only and must not be given intrathecally.
How many Unicristin vials should you order?
Calculate the prescribed dose, vial size, doses per treatment cycle, unavoidable wastage, and reserve stock. Use vial utilization rather than price per vial alone.
What should a Lima buyer verify before ordering Unicristin?
Check the product identity, batch number, expiry date, storage conditions, cold-chain records, Peruvian authorization, and the supplier’s supporting documents.
